RBM25 and hydrops fetalis: Further analysis demonstrated that administration of the p38 MAPK inhibitor SB203580 (HF + OE‐RBM25 + SB203580 group) significantly reduced the myocardial infarction area compared to the HF + OE‐RBM25 group (p < 0.05).